Cell Therapy Next Current Issue

The following articles appeared in the print edition of Cell Therapy Next.

Table of Contents

• Developing a Pause Button for CAR T-Cell Therapy
• Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
• HA-1 T TCR T Cell Immunotherapy for the Treating of Patients with Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
• HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
• NY-ESO-1 TCR Engineered T Cell and HSC After Melphalan Conditioning Regimen in Treating Participants with Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer
• T-cell Responses to Concurrent HIV and Herpesvirus Infections
• TCR-engineered T Cells in Solid Tumors (ACTengine)
• FDA Grants Fast Track Designation to Cell Therapy for Degenerative Disk Disease
• FDA Grants Orphan Drug Status to Anti-BCMA CAR T-cell Therapy for Multiple Myeloma
• FDA Provides Pathway to BLA Approval for Chronic Heart Failure Cell Therapy
• Mustang Bio’s CAR T-cell Therapy Receives Orphan Drug Designation for AML
• Hope vs Hype: Managing Patient Expectations for CAR T-Cell Therapy
• CAR T-cell Therapy Shows Activity in Lymphoma Despite Lack of Measurable Disease
• Stem Cell Therapy Safe, Feasible in Congenital Heart Defect Surgery
• Nonengineered T-cells May be ‘Clinically Meaningful’ for Pancreatic Cancer
• Cameron Turtle Receives Fred Hutch’s Endowed Chair for Immunotherapy
• CAR T-cell Therapy Made Available to All Medicare Recipients
• CMS Increases CAR T Reimbursement by 15%
• RFTCA Purchases Cell-Based Technology to Develop Cure for HIV/AIDS
• Stanford, Johns Hopkins Cancer Researchers Share Albany Prize